During vertebrate embryogenesis, hematopoietic stem cells (HSCs) arise in the aorta-gonads-mesonephros (AGM) region. We report here that blood flow is a conserved regulator of HSC formation. In zebrafish, chemical blood flow modulators regulated HSC development, and silent heart (sih) embryos, lacking a heartbeat and blood circulation, exhibited severely reduced HSCs. Flow-modifying compounds primarily affected HSC induction after the onset of heartbeat; however, nitric oxide (NO) donors regulated HSC number even when treatment occurred before the initiation of circulation, and rescued HSCs in sih mutants. Morpholino knockdown of nos1 (nnos/enos) blocked HSC development, and its requirement was shown to be cell autonomous. In the mouse, Nos3 (eNos) was expressed in HSCs in the AGM. Intrauterine Nos inhibition or embryonic Nos3 deficiency resulted in a reduction of hematopoietic clusters and transplantable murine HSCs. This work links blood flow to AGM hematopoiesis and identifies NO as a conserved downstream regulator of HSC development.
INTRODUCTION
Definitive hematopoietic stem cells (HSCs) that are capable of self-renewal and production of all mature blood lineages arise during embryogenesis. Both the timing of HSC induction and the gene programs regulating this process are well conserved across vertebrate species (Orkin and Zon, 2008) . Additionally, factors that affect HSC specification during embryogenesis often similarly function in HSC maintenance and/or recovery after marrow injury. The identification of factors that regulate HSC induction during embryogenesis is of significant therapeutic interest.
Murine transplantation studies revealed that adult-type longterm repopulating (LTR) HSCs arise in the aorta-gonads-mesonephros (AGM) region between embryonic day 10.5 (e10.5) and e11.5 (Dzierzak and Medvinsky, 2008) . Transplantable HSCs localize to the ventral wall of the dorsal aorta and express phenotypic markers of mesenchymal, endothelial, or hematopoietic cell types. Runx1, commonly affected in childhood and adult leukemia (Downing et al., 1993; Golub et al., 1995) , is required for the formation of functional HSCs (North et al., 1999 (North et al., , 2002 Wang et al., 1996) ; its expression is highly conserved across vertebrate species (Orkin and Zon, 2008) . Based on the functional conservation of AGM hematopoiesis from fish to man, an evolutionary advantage or necessity for the production of stem cells within the aorta must exist. To identify genes that regulate HSC formation, we conducted a chemical genetic screen for regulators of runx1/cmyb+ cells in the zebrafish AGM at 36 hr postfertilization (hpf). We have previously identified PGE2 as a potent regulator of both HSC induction and marrow repopulation across vertebrate species (North et al., 2007) . The wnt pathway similarly regulates stem cell production during embryogenesis, and genetically interacts with PGE2 (Goessling et al., 2009 ). The identification of novel regulators of this process will aid in connecting the complex network of signaling pathways that control both HSC development during embryogenesis and marrow regulation in the adult.
Nitric oxide (NO) plays a key role in the regulation of vascular tone, angiogenesis, and endothelial migration (Davies, 1995; Lucitti et al., 2007) . As HSCs are derived from hemogenic endothelial cells within the dorsal aorta, NO produced locally in endothelial cells could link blood flow and HSC formation. NO has been detected in blood cells and extends replating ability in hematopoietic culture, presumably by maintaining HSCs in a quiescent state in vitro (Krasnov et al., 2008) . While NO function in the adult hematopoietic stroma is thought to have a positive effect on hematopoiesis, data from knockout mice imply that NO production is detrimental to hematopoietic repopulation and recovery after injury (Michurina et al., 2004) ; this effect, however, may be due to NO-related superoxide complexes induced by irradiation (Epperly et al., 2007) . The role of NO in HSC induction in the vertebrate embryo is currently uncharacterized.
Here, we show that a diverse group of compounds that regulate blood flow affect the production of runx1/cmyb+ HSCs. In general, compounds that increased blood flow enhanced HSC number, whereas chemicals that decreased blood flow diminished HSCs. silent heart (sih) embryos that lack a heartbeat and fail to establish blood circulation had impaired HSC formation. Compounds that increase NO production could modify HSC formation when exposure occurred prior to the initiation of circulation and rescue HSC production in sih mutants. Inhibition of NO production blocked the inductive effect of several blood flow modulators on HSCs, suggesting that NO serves as the connection between blood flow and HSC formation. In the mouse, NO synthase 3 (Nos3; eNos) is expressed in AGM endothelium and hematopoietic clusters, and marks LTRHSCs. Intrauterine Nos inhibition reduced transplantable HSCs; similar results were found for the Nos3 À/À knockout mice. Our work provides a direct link between the initiation of circulation and the onset of hematopoiesis within the AGM and identifies NO signaling as a conserved regulator of HSC development.
RESULTS

Modulators of Blood Flow Regulate HSC Formation
A chemical genetic screen was conducted to identify regulators of AGM HSC formation (North et al., 2007) . Of the chemicals found to regulate runx1 and cmyb coexpression by in situ hybridization at 36 hpf, several were known modulators of heartbeat and blood flow. These compounds were categorized into distinct classes on the basis of their hemodynamic mechanism of action (Figure S1A available online). Well-established agonists and antagonists of each category were secondarily screened for effects on HSCs ( Figures 1A-1L Figure 1G , 56 inc/79). NO is a well-established direct regulator of vascular tone and reactivity, thereby influencing blood flow. The NO donor S-nitroso-N-acetyl-penicillamine (SNAP) (10 mM) caused a significant increase in HSC development (69 inc/93). In contrast, the Nos inhibitor N-nitro-L-arginine methyl ester (L-NAME) (10 mM) diminished runx1/cmyb expression (Figures 1E and 1K, 58 dec/90) . Exposure to the angiotensin-converting enzyme (ACE) inhibitor enalapril decreased HSC number ( Figure 1F , 42 dec/81). These findings were corroborated by qPCR for runx1 ( Figure 1M ).
Conserved vascular responses of each chemical class were demonstrated by in vivo confocal microscopy of fli:GFP; gata1:dsRed transgenic zebrafish (n = 5/compound) at 36 hpf ( Figures 1N and S2) (Eddy, 2005) . These data correlated with prior zebrafish studies (Fritsche et al., 2000) . Vasodilation of the artery and vein was accompanied by increased passage of total blood volume, as seen by digital motion analysis of gata1+ red blood cells (RBCs; data not shown); vasoconstriction caused RBCs to traverse only in single file. Together with the in situ hybridization studies, these experiments reveal that increases in vessel diameter typically were coincident with increased runx1 expression, and vice versa.
We have previously utilized microarray analysis of sorted cell populations isolated during various stages of embryogenesis to document cell-type and developmental specificity of genes of interest (North et al., 2007; Weber et al., 2005) . We found components of the NO (nos1), angiotensin (ace2, agtrl1a, agt), and adrenergic signaling (adra2b, adra2 da, adra2c) pathways expressed in the HSC compartment ( Figure S1B ). Most were more highly expressed during the definitive wave of hematopoiesis after the onset of the heartbeat and circulation, consistent with their role in regulating hemodynamic homeostasis. These data confirm that vascular tone and flow-modifying components are present and responsive to chemical manipulation in the AGM and imply that modulation of blood flow could have a significant impact on HSC formation during embryonic development.
Absence of a Heartbeat Causes Failures in Definitive HSC Development
In the zebrafish, the occurrence of vigorous blood circulation through the tail is coincident with HSC formation in this region (T.E.N. and L.I.Z., unpublished data). In order to establish the importance of blood flow for initiation of HSC formation, we examined sih mutant zebrafish embryos, which lack a heartbeat due to a mutation in cardiac troponin T (Sehnert et al., 2002) . runx1/cmyb expression was dramatically reduced in sih À/À embryos (Figures 2A and 2E, 69 dec/77) . In contrast, the vascular marker flk1 was minimally affected (Figures 2B and 2F) , consistent with previous observations (Isogai et al., 2003) . ephrinB2, a marker of arterial identity, was reduced in sih embryos (Figures 2C and 2G, 55 dec/74) , while expression of the venous marker flt4 was increased ( Figures 2D and 2H , 33 inc/61). These results were confirmed by qPCR ( Figure 2I , p < 0.05, n = 3). In contrast, benzidine staining for RBCs as well as in situ hybridization for the erythroid marker globin and the myeloid marker myeloperoxidase (mpo) show distribution differences due to lack of blood circulation in sih mutants, but no gross quantitative changes (Figures 2J, 2K, . Myosin heavy chain (mhc), a marker of somitogenesis, and the endodermal progenitor marker foxa3 were also not affected. These data demonstrate that the absence of a beating heart and subsequent failure to establish circulation specifically impairs arterial identity and HSC formation.
Nitric Oxide Signaling Can Affect HSC Formation prior to the Initiation of Flow To further investigate the role of circulation in the initiation of HSC development, we exposed zebrafish embryos to blood flow-modulating agents either before (10 somites-23 hpf) or after (26-36 hpf) the onset of heartbeat and assessed HSC development at 36 hpf. All compounds examined increased HSC formation when used after the heartbeat began ( Figures 3A, 3C , 3E, and 3G). In contrast, only SNAP was capable of enhancing HSC number at 36 hpf when treatment was completed before the heartbeat was established ( Figures 3B, 3D , and 3F). Likewise, the NO inhibitor L-NAME could reduce HSC formation when treatment occurred prior to the initiation of the heartbeat ( Figure 3A) . The effects of L-NAME and SNAP were dose dependent over a range of 1-100 mM (Figures S4A-S4L ) and specific to the HSC compartment, with mild effects on the vasculature, but not on globin, mpo, mhc, or foxa3 expression ( Figures S5A-S5R ). Additionally, changes were only observed during the definitive hematopoietic wave and were maintained into larval stages ( Figures S6A-S6O ). In addition to SNAP ( Figure 3K , 18 inc/25), NO donors sodium nitroprusside (SNP; Figure 3N , 20 inc/31) and L-arginine (L-arg; Figure 3I , 15 inc/25) (Pelster et al., 2005; Pyriochou et al., 2006) enhanced runx1/cmyb expression ( Figures 3I, 3K, and 3N ), while the nonspecific nos inhibitor, N-monomethyl-L-arg acetate (L-NMMA; Figure 3O , 17 dec/29) diminished HSCs like L-NAME ( Figure 3L , 16 dec/26). Inactive (N) Effect of drug treatment on the diameter of the dorsal aorta in vivo. Transgenic fli:GFP fish were treated with chemicals and imaged by confocal microscopy at 36 hpf; all treatments were statistically significant from the control (mean ± SD, ANOVA, p < 0.001).
D-enantiomers had no effect ( Figures 3J, 3M , and 3P). To assess whether modification of runx1/cmyb expression correlated with a quantifiable effect on HSC number, we utilized cmyb:GFP; lmo2:dsRed reporter fish (North et al., 2007) . Confocal microscopy revealed increased HSC (yellow) numbers after SNAP exposure, and a reduction after L-NAME treatment (Figures 3Q-3S and S5S, p < 0.001, n = 5). TUNEL analysis indicated that L-NAME could affect HSC by induction of apoptosis . These analyses indicate that HSC modulation by the majority of flow-modifying compounds requires the establishment of blood circulation and that NO signaling is the mediator of blood flow in this process.
HSC Formation Is Affected by Signals Downstream of NO
To clarify that the effect of flow on HSCs was mediated by NO signaling, we studied downstream components of the NO signaling cascade by chemical manipulation. The soluble guanyl cyclase inhibitor 1H-oxadiazolo-quinoxalin-1-one (ODQ) prevents cGMP formation in response to NO signaling; it regulates vascular remodeling and blood flow in zebrafish in a dose-and time-dependent manner (Pyriochou et al., 2006) . ODQ (10 mM) caused a profound decrease in HSCs (Figures 3T and 3U, 27 dec/43) and also blocked the effects of SNAP (Figures 3W and 3X, 8 inc/38) . Phosphodiesterase (PDE) V converts cGMP to GTP. The PDEV inhibitor 4-{[3 0 ,4 0 -methylene-dioxybenzyl]amino}-6-methoxyquinazoline (MBMQ, 10 mM) increased HSCs ( Figure 3V , 35 inc/43) and further enhanced the effects of SNAP ( Figure 3Y , 40 inc/46). These data highlight the specificity of cGMP as a downstream effector of NO signaling in HSC formation.
NO Signaling Rescues HSCs in sih À/À Embryos
To confirm a direct role for NO in HSC induction, we exposed sih embryos to SNAP. SNAP rescued runx1/cmyb expression toward wild-type (WT) levels in the majority of sih embryos examined ( Figures 4A-4D , 31 normal/51). These results were confirmed by qPCR ( Figure 4E ). SNAP also normalized ephB2 defects in sih mutants (Figures 4F-4I, 18 inc/27; Figure S8A ). L-arg and SNP (data not shown), as well as bradykinin, a potent vasodilator that stimulates NO production, increased HSCs, and rescued the sih hematopoietic defect (Figures S8B-S8E). To further characterize the relationship between blood flow, NO signaling, and HSC induction, we concomitantly exposed WT embryos to flow-modifying drugs and L-NAME (10 mM). As the majority of flow-regulating compounds that enhance HSCs also cause vasodilation and increase total blood flow through the aorta, they may directly trigger NO production by alterations in sheer stress, pulsatile flow, or soluble signaling components. L-NAME treatment prevented the increase in HSC formation caused by most compounds tested ( Figures 4J-4U ). These data further point to NO signaling as the direct link between blood flow and HSC development.
Nos1 Is Required for HSC Formation
Zebrafish lack genomic evidence for endothelial NO synthase (enos, nos3); however, we, and others (Pelster et al., 2005) , observed eNos immunoreactivity in the tail region, where the HSCs develop ( Figures S9J-S9L ). Phylogenetic and genomic examination demonstrates that neuronal nos (nnos, nos1) (Poon et al., 2003) and nos3 (enos) are highly related. Morpholino antisense oligonucleotide (MO) knockdown of nos1 had a 5G , and 5H): selective inhibition of nos1 by S-methyl-L-thiocitrulline (10 mM; 30 dec/44) severely diminished HSC number, whereas the nos2 (inos)-specific inhibitor 1400W (10 mM; 4 dec/49) only minimally affected HSCs. These data suggest that nos1 (nnos/enos) is required for HSC formation in zebrafish, which is supported by nos1 expression in both endothelial cells and HSCs ( Figure S1B ). Interestingly, in sih À/À embryos, nos1 was significantly decreased ( Figure 5I , p < 0.001); in contrast, nos2 was not significantly changed. Further, nos1, but not nos2, was significantly altered in response to chemical alteration of blood flow (Figures 5J and 5K, p < 0.003). These data support the hypothesis that nos1 is the functionally relevant connection between blood flow and HSC development.
The Effect of NO Signaling on HSC Formation Is Cell Autonomous
In order to examine cell autonomy and delineate the role of NO signaling in the HSC and surrounding hematopoietic niche, we employed a blastula transplant strategy. Cells harvested from cmyb:GFP embryos injected with control or nos1 MO were transplanted at the blastula stage into lmo2:dsRed recipients. In this transplant scheme, donor-derived HSCs appear green ( Figure S10A ) in the red fluorescent endothelial/HSC compartment ( Figures 6A  and S10B ). Sixty-two and a half percent of embryos examined had GFP+ HSC formation derived from control-injected donor cells ( Figures 6B and 6D ), while none of the nos1 MO injected donor cells gave rise to green HSCs ( Figures 3C and 3D , p = 0.0065); successful transplants were indicated by the contribution of cmyb+ donor cells to the recipient eye. In a reciprocal experiment, we found that uninjected lmo2:dsRed donor cells contributed to endothelial and HSC development in cmyb:GFP recipients ( Figure S10C ), particularly after MO knockdown in the recipient. These experiments formally demonstrate that nos1 acts in a cell-autonomous manner in the hemogenic endothelial cells.
Developmental Signaling Pathways Interact with NO in HSC Formation
Developmental regulators such as the notch and wnt pathways have been linked to HSC formation and self-renewal (Burns et al., 2005; Goessling et al., 2009) . Due to the effect of NO on HSC specification and expansion, potential interaction with notch and wnt signaling was examined. The notch pathway influences arterial/venous identity and functions upstream of runx1 in HSC specification; mindbomb (mib) mutants lack HSCs because of a deficiency of notch signaling (Burns et al., 2005) (33 dec/47). SNAP rescued HSC formation in these mutants (Figures S11A-S11D ; 27 normal/43). Transgenic zebrafish embryos expressing an activated form of the notch intracellular domain (NICD) exhibit enhanced HSC numbers (55 inc/62); L-NAME blocked the HSC increase (Figures S11E-S11H ; 16 inc/63) and inhibited NICDmediated elevation of ephB2 expression in the aorta ( Figures  S12A-S12D ). These studies imply that NO functions downstream of notch in regulation of arterial identity and/or in HSC induction.
Recent studies have shown that modulation of the wnt pathway affects HSCs (Goessling et al., 2009; Reya et al., 2003) . We used heat-shock-inducible transgenic zebrafish embryos expressing negative (dkk) and positive (wnt8) regulators of wnt signaling to evaluate the interaction between the wnt and NO signaling cascades (Goessling et al., 2008) . Induction of dkk reduced HSC number (16 dec/8) and was rescued by SNAP (Figures S13A-S13D; 5 dec/33). In contrast, wnt8 enhanced HSC formation (22 inc/30), which was blocked by L-NAME (Figures S13E-S13H; 9 inc/28). In support of these findings, previous studies have shown an interaction of both the notch and wnt pathways with NO, although the directionality of these interactions varies (Du et al., 2006; Ishimura et al., 2005; Prevotat et al., 2006) .
The Relationship between NO and HSC Induction Is Conserved in the Mouse
To document a role for NO in murine HSC formation, we examined Nos3:GFP expression in the AGM. Histological sections of e11.5 embryos showed endothelial cells lining the dorsal aorta (D and F) MO (ATG and splice site) against nos2 (40 mM) had no effect on HSC development. (B, G, and H) Chemical nos inhibition confirmed the specific requirement for nos1: embryos exposed to nonspecific (L-NAME; 10 mM) and nos1-selective (S-methyl-L-thiocitrulline; 10 mM) inhibitors demonstrated decreased HSC formation; nos2-selective inhibition (1400W; 10 mM) had minimal impact. (I) WT and sih À/À embryo extracts (n = 20) were subjected to qPCR (mean ± SD; * nos1, WT versus sih, t test, p < 0.001, n = 3; nos2, WT versus sih, p = 0.385, n = 3.).
(J and K) Effect of flow-modifying chemicals (10 mM, 10 somites-36 hpf) on nos1 and nos2 expression; nos1 is significantly regulated by most compounds tested. Mean ± SD; * significant versus control, ANOVA, p < 0.01, n = 3.
expressing high levels of Nos3 ( Figures  S14A-S14D Figure S14E ). Transplantation of Nos3 AGM subfractions into irradiated adult recipients demonstrated that LTR-HSCs are enriched within the Nos3 med population ( Figure S14F ). To demonstrate a conserved functional requirement for NO signaling in HSC/ progenitor formation, we exposed pregnant mice to L-NAME (2.5 mg/kg intraperitoneally) or vehicle control and compared effects on the AGM HSC and progenitor populations at e11.5. NO inhibition produces implantation defects in early pregnancy (Duran-Reyes et al., 1999) and can alter yolk sac angiogenesis (Nath et al., 2004) ; interestingly, Nos3 deficiency caused significant lethality from e8.5 to 13.5 during the time when definitive HSCs are formed (Pallares et al., 2008) . L-NAME treatment at e8.5 produced severely delayed embryos that lacked the majority of both extra-and intraembryonic blood vessels (data not shown). L-NAME treatment at e9.5 and e10.5 at prevented gross morphological abnormalities of the yolk sac, placenta, or embryo. Histological analysis of the AGM region revealed that L-NAME caused the disappearance of hemogenic endothelial clusters, which was confirmed by phenotypic FACS analysis ( Figures 7A-7L and S15A-S15G) . Similarly, analysis of e11.5 Nos3 À/À embryos revealed a significant decrease in the AGM Sca1+/cKit+ and CD45+/VE-Cadherin+ populations, which was confirmed histologically; Nos3 À/À embryos displayed a reduction in the number and size of the hematopoietic clusters ( Figure 7K ). HSC induction was grossly normal in Nos1 À/À animals ( Figure 7L ).
To examine effects on HSC function, we performed transplantation studies using single-cell suspensions of subdissected AGM tissue from WT, L-NAME-exposed, and Nos3 À/À embryos at e11.5. Progenitor activity as measured by spleen colony formation at days 8 and 12 after transplantation was diminished in L-NAMEexposed ( Figure S15J , p < 0.001) and Nos3 À/À ( Figure 7M , p < 0.001) embryos. Multilineage repopulation after 6 weeks revealed significantly diminished peripheral blood (PB) chimerism ( Figures  7N and S15K , p > 0.05) and engraftment rates ( Figure S15L ) for recipients of both L-NAME-exposed and Nos3 À/À AGM cells.
These results indicate a conserved role for NO signaling in the regulation of hematopoietic stem/progenitor formation and function during embryonic development. Although at reduced numbers, Nos3 À/À embryos develop to adulthood and lack significant steady-state peripheral blood abnormalities; our data suggest that while impaired initially, some functional HSCs do arise in Nos3 À/À embryos. Interestingly, although the Nos3 À/À animals exhibit some residual HSC production, L-NAME-exposed embryos do not possess AGM HSCs, implying that functional redundancy with other Nos family members must occur. .5 and transplanted into sublethally irradiated recipients. L-NAME exposure or Nos3 deletion in embryos significantly reduced CFU-S12 spleen colony formation (mean ± SD; * sig versus control; p < 0.001; ** sig versus L-NAME; p < 0.05; ANOVA, n R 5) (M). Diminished NO signaling significantly decreased embryonic donor cell chimerism rates in individual recipient mice at 6 weeks after transplant (* sig versus control, p < 0.05, ANOVA, n R 5) (N).
DISCUSSION
The purpose of a beating heart and circulation at embryonic stages where diffusion is still sufficient for oxygenation of developing tissue has long been a source for speculation (Burggren, 2004; Pelster and Burggren, 1996) . Through a chemical screen in zebrafish, small molecules that regulate vascular dynamics were found to influence HSC development; intriguingly, changes in HSC formation were coupled to blood flow and NO production. Our data imply that circulation itself, through NO induction, signals to trigger the onset of definitive hematopoiesis, thereby ensuring proper timing of blood cell development to support additional hematopoietic requirements during accelerated growth in fetal/larval stages. Significantly, we found that the enhancing role of NO in HSC induction is conserved from fish to mammals. NO production can be induced by sheer stress and alterations in blood flow (Fukumura et al., 2001 ). The coincident timing of HSC induction with the achievement of vigorous pulsatile flow implies that the latter may serve as the physiologic inductive signal for NO in the AGM. Pulsatile flow achieved by a regular heartbeat has been shown to trigger NO production in the endothelium (White and Frangos, 2007) . The data from the silent heart embryos-as well as observations in Ncx1 À/À mice Rhodes et al., 2008) , which also fail to establish circulation due to heart-specific defects-indicate that in the absence of flow there are alterations in specification, budding, and shedding of HSCs from endothelial hematopoietic clusters. It will be intriguing to further decipher the correlation between flow rate and total AGM HSC number; MO knockdown of tnnt2 (sih) (Bertrand et al., 2008; Murayama et al., 2006; Jin et al., 2009 ) and analysis of incompletely penetrant sih mutants with occasional heartbeats (data not shown) show less-severe reductions in HSC number, implying that small bursts of NO production may be sufficient to trigger HSC induction. As NO can regulate endothelial cell movement and processes resembling HSC budding, such as podokinesis, by altering cell-cell adhesions and actin conformation (Noiri et al., 1998) , it could directly control the formation and stability of hematopoietic clusters once flow is established. Confirming this conjecture, we determined that there is a cell-autonomous role of NO signaling during hematopoietic development, where the hemogenic endothelial population must be capable of NO production to support subsequent HSC formation in the AGM.
We found that NO may additionally function to establish the AGM vascular niche prior to HSC formation; our data showing significant alterations in ephrinB2 staining in the absence of flow support the concept that flow itself plays a role in maintaining vascular identity. NO is a well-characterized regulator of angiogenesis and is required for murine yolk sac vasculogenesis (Nath et al., 2004) . Prior studies in the zebrafish embryo showed that chemical inhibition of NO production/signaling by L-NAME or ODQ during somitogenesis produces vascular abnormalities (Pyriochou et al., 2006) . Since definitive HSCs are formed within the major embryonic arteries (de Bruijn et al., 2000) , any alterations in NO signaling and subsequent vessel development would negatively impact HSC number. As ephrinB2 and arterial identity are established by notch signaling (Lawson et al., 2001) , the interaction of the notch and NO pathways may be particularly relevant for HSC formation. NO may initiate arterial specification early during development and may maintain arterial identity once flow is established. This is in agreement with reports that demonstrate that arterialization is an ongoing and flow-dependent process, influenced by NO (Teichert et al., 2008) . Similarly, vascular endothelial growth factor (VEGF), a potent vascular mitogen regulated by both notch and wnt, is a well-characterized inducer of NO production (Fukumura et al., 2001 ). In the dorsal aorta, VEGF may increase NO production and signaling to cause the vascular remodeling required for the production of the hematopoietic clusters.
Our data demonstrate both a requirement for and enhancing response to NO signaling for AGM HSC development. Several nos isoforms have been identified in zebrafish: nos1, which is expressed in developing neural tissues as well as the gut, kidney, and major vessels (Holmqvist et al., 2004; Poon et al., 2003) , and two isoforms of nos2. While genomic evidence for the presence in zebrafish of nos3 is lacking (Pelster et al., 2005) , immunoreactivity to eNos antibodies suggests the conservation of the functional epitope (Fritsche et al., 2000) . As NO-mediated vascular reactivity is clearly present in fish and nos1 and nos3 are highly related at both the sequence and structural levels, nos1 likely assumes the role of vascular NO production in fish. Nos1 is genetically complex with individual splice forms showing tissue-specific expression, and it is likely that one form of nnos acts enos-like in zebrafish. In support of this hypothesis, our microarray analysis demonstrated nos1 expression in CD41+ HSCs and the vascular niche.
In the murine AGM, phenotypic and histological analysis showed that Nos3 (eNos) is expressed in HSCs and required for stem cell function. Conversely, we found Nos1 (nNos) not to be essential for HCS formation under normal developmental conditions. Interestingly, Nos3 and Nos1 are both expressed in the fetal liver shortly after AGM HSC formation and could play a role in the developmental regulation and expansion of HSC and progenitor populations (Krasnov et al., 2008) . Their coexpression suggests a functional redundancy in mammalian HSCs that could explain the impaired, but present, HSC formation and adult viability of Nos3 À/À embryos. Consequently, global NO inhibition by L-NAME had a much more severe effect on HSC formation. It remains to be determined whether differences in hematopoietic development occur in mice in which all Nos isoforms are disrupted.
NO donors positively affect multipotent hematopoietic progenitors in vitro (Michurina et al., 2004) ; additionally, the ability of stromal cell lines to support stem cell maintenance corresponds with NO production (Krasnov et al., 2008) . In contrast, others have shown that NO inhibition enhances HSC engraftment after transplantation (Krasnov et al., 2008; Michurina et al., 2004) . While these studies imply that NO may have a negative effect on adult HSCs, parallel work has shown that NO is induced by ionizing irradiation and that the absence of Nos diminishes superoxide and peroxide damage (Epperly et al., 2007) . These data preclude a clear interpretation of transplantation/repopulation studies where the hematopoietic niche is cleared via irradiation. After 5-fluorouracil bone marrow injury, Nos3 À/À mice show impaired regeneration, indicating an important role for Nos3 in stem and progenitor cell function in vivo after marrow injury (Aicher et al., 2003) . Taken together with the results presented here, these studies indicate that the effects of NO are likely highly time and context dependent, and further work is needed to decipher the role of NO in regulating adult hematopoietic homeostasis and maintaining both the stromal and vascular niche.
Our study demonstrates that definitive hematopoietic stem cell formation in the developing embryo is dependent on the induction of the heartbeat and establishment of circulation. Two models have been proposed for the relationship of blood formation in murine extraembryonic tissues and the embryo proper: in one model, the stem cells arise independently in discrete locations in the embryo and extraembryonic tissues and subsequently colonize the fetal liver (Dzierzak and Speck, 2008; Rhodes et al., 2008) , whereas the other proposes that cells from the extraembryonic tissues traverse circulation to colonize the intraembryonic hematopoietic sites (Palis and Yoder, 2001) . A recent study using the Ncx1 À/À mouse showed that yolk sac hematopoietic progenitors could form in the absence of blood flow, while the appearance of progenitors in the embryo proper was greatly impaired; these data were interpreted to show that it is yolk sac-derived embryonic progenitors that traverse the circulation and seed the fetal liver . Our data imply that the contemporaneous establishment of circulation and the appearance of HSCs within the embryo proper may not simply reflect the transit of HSCs formed in extraembryonic tissues to colonize the aorta and fetal liver, but rather that the circulation functions directly to provide inductive signals to specific regions of the embryonic vasculature, making it competent to produce HSCs de novo.
Here, we established a conserved role for NO in the developing hematopoietic system. NO can function in vessel formation and specification, blood flow regulation, and hematopoietic cluster formation, suggesting that it is required in the vascular niche for HSC production. Although the function of NO in the adult marrow is complex, our findings during embryogenesis indicate that modulation of blood flow or NO signaling might be therapeutically beneficial for patients undergoing stem cell transplantation.
EXPERIMENTAL PROCEDURES Zebrafish Husbandry
Zebrafish were maintained according to Institutional Animal Care and Use Committee protocols. fli: GFP, hs:gal4; uas:NICD, wnt8:GFP, dkk1 :GFP transgenic and sih and mib mutant fish were described previously (Burns et al., 2005; Goessling et al., 2009; Itoh et al., 2003; Lawson and Weinstein, 2002; Sehnert et al., 2002) . Embryonic heat shock was conducted as described (Goessling et al., 2009 ).
Mice
Embryos were generated from C57Bl/6, Runx1:lacZ (North et al., 1999 ), Nos3:GFP transgenic (van Haperen et al., 2003 , Nos1 À/À , and Nos3 À/À mice. Vaginal plug identification was considered e0.5. Animals were handled according to institutional guidelines.
In Situ Hybridization
Paraformaldehyde-fixed embryos were processed for in situ hybridization according to standard zebrafish protocols (http://zfin.org/ZFIN/Methods/ ThisseProtocol.html). The following RNA probes were used: runx1, cmyb, flk1, ephrinB2, flt4, globin, mpo, mhc, and foxa3. Changes in expression compared to WT controls are reported as the number altered/number scored per genotype/treatment (North et al., 2007) ; a minimum of three independent experiments was conducted per analysis.
Chemical Exposure
Zebrafish embryos were exposed to chemicals at the doses indicated; dimethyl sulfoxide (DMSO) carrier content was 0.1%. For evaluation of HSC development, exposure ranged from early somitogenesis (5+ somites) until 36 hpf, unless otherwise noted.
Morpholino Injection
Morpholino (MO; GeneTools) designed against the ATG and exon1 splice sites of nos1 (5 0 -ACGCTGGGCTCTGATTCCTGCATTG; 5 0 -TTAATGACATCCCTC ACCTCTCCAC) and nos2 (5 0 -AGTGGTTTGTGCTTGTCTTCCCATC; 5 0 -ATGC ATTAGTACCTTTGATTGCACA), and mismatched controls were injected into one-cell-stage embryos.
Confocal Microscopy
Fluorescent reporter embryos were exposed to blood flow modulators (10 mM, unless otherwise noted) as indicated, live embedded in 1% agarose, and imaged with a Zeiss LSM510 Meta confocal microscope at 36 hpf (North et al., 2007) or a Perkin Elmer UltaVIEW VoX spinning disk confocal microscope.
qPCR qPCR was performed on cDNA obtained from whole embryos at 36 hpf (n = 20/ variable; primers listed in Table S1 ) as previously described (North et al., 2007) , with SYBR Green Supermix on the iQ5 Multicolor RTPCR Detection System (BioRad).
Blastula
Transplantation cmyb:GFP embryos were injected with nos1 or control MO at the one-cell stage. At the blastula stage, 100 cells were removed from the donor embryo and transplanted into stage-matched recipients. Embryos were analyzed by confocal microscopy at 36 hpf.
Murine AGM Histology At e11.5 after timed mating, embryos dissected from the uterus and processed for histological evaluation. Paraffin serial sections were stained with hematoxylin and eosin; cryosections were assessed by fluorescence microscopy for GFP. X-Gal staining was performed as indicated.
Nos3:GFP AGM FACS Analysis
Embryos (e11.5) from Nos3:GFP transgenic animals were isolated, and AGM tissue was dissected and disaggregated. Flow cytometric analysis was performed for Nos3:GFP, VE-Cadherin, CD34, Sca-1, c-kit, and CD45 (BD Pharmingen).
Nos3:GFP AGM Transplantation
Transgenic AGM cells were sorted into Nos3:GFP fractions. AGM (one embryo equivalent) cell suspensions were injected into irradiated (9 Gy) FVB recipient mice with adult spleen carrier cells (2 3 10 5 per recipient). Recipient peripheral blood was analyzed at 4 months after transplantation for donor-derived cells by DNA PCR for GFP (donor marker) and myogenin (normalization control). Recipients with >10% donor-marked cells were considered positive.
AGM Transplantation and Progenitor and LTR HSC Analysis
AGM transplantations were performed with the CD45.1/45.2 allelic system. Pregnant C57Bl/6 females were injected with DMSO or L-NAME (2.5 mg/kg) intraperitoneally on e9.5 and e10.5. WT, L-NAME, Nos1
, and Nos3 À/À AGM regions were dissected and disaggregated at e11.5 then injected into 8-week-old C57Bl/6 sublethally irradiated recipients. For CFUS8 and 12 analyses, spleens were dissected, weighed, and fixed with Bouin's solution, and hematopoietic colonies were counted. For long-term transplants, PB obtained from recipient mice at 6 weeks was analyzed for donor chimerism and multilineage engraftment (>1%) by FACS. 
